2'-Methylspiro[bicyclo[2.2.1]heptane-2,5'-[1,3]dioxane]
Common Name: |
2'-Methylspiro[bicyclo[2.2.1]heptane-2,5'-[1,3]dioxane] |
IUPAC Name: |
2-methylspiro[1,3-dioxane-5,2'-bicyclo[2.2.1]heptane] |
Molecular Formula: |
C11H18O2 |
SMILES: |
CC1OCC2(CC3CCC2C3)CO1 |
Inchi: |
1S/C11H18O2/c1-8-12-6-11(7-13-8)5-9-2-3-10(11)4-9/h8-10H,2-7H2,1H3 |
Inchi Key: |
HSNHBDAGWWAPOE-UHFFFAOYSA-N |
Cas No: |
87641-24-5 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
0 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
1 |
Name |
Value |
Molecular Weight (g/mol) |
182.26 |
Mass (g/mol) |
182.131 |
Molar Refractivity |
50.56 |
Net Charge |
|
HBD |
|
HBA |
2 |
Rt Bonds |
0 |
Rings |
3 |
TPSA |
18.46 |
Hetero Atoms |
2 |
Heavy Atoms |
13 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
67.00 to 70.00 @ 1.70 mm Hg |
Vapor Pressure (mmHg@25.00 °C) |
0.113 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
1.00 |
LogP |
2.186 |
iLOGP |
2.61 |
XLOGP3 |
2.39 |
WLOGP |
2.19 |
MLOGP |
2.22 |
ESOL Log S |
-2.48 |
ESOL Solubility (mg/ml) |
0.61 |
ESOL Solubility (mol/l) |
0.003 |
ESOL Class: esol_class |
Soluble |
Ali Log S |
-2.42 |
Ali Solubility (mg/ml) |
0.7 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Soluble |
Silicos-IT LogSw |
-1.81 |
Silicos-IT Solubility (mg/ml) |
2.8 |
Silicos-IT Solubility (mol/l) |
0.02 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-5.71 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.839 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
0.503 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |